DiaGenic ASA ASA: Report From Second Quarter 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

DiaGenic (OSE:DIAG):

The interim report for the second quarter 2013 was approved by the Board of Directors on 22 August 2013. Please find the interim report and presentation attached.

Highlights from the report:

•On 2 April 2013 the Extraordinary General Meeting of DiaGenic resolved the private placement and subsequent offering at a price of NOK 0.60 per share.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC